“The Cost of Cancer Drugs”

Recently, 60 Minutes ran a story about the inflated prices of new cancer drugs.

Here is how the segment began (from 60 Minutes website):

Cancer is so pervasive that it touches virtually every family in this country. More than one out of three Americans will be diagnosed with some form of it in their lifetime. And as anyone who’s been through it knows, the shock and anxiety of the diagnosis is followed by a second jolt: the high price of cancer drugs.

They are so astronomical that a growing number of patients can’t afford their co-pay, the percentage of their drug bill they have to pay out-of-pocket. This has led to a revolt against the drug companies led by some of the most prominent cancer doctors in the country

“How to Save $1 Billion Without Even Trying:” The Economics of Generics

The most recent episode of the Freakonomics podcast was titled, “How to Save $1 Billion Without Even Trying.”  It discusses how consumers can save by purchasing generic, as opposed to name brand, products.  The podcast discusses generic medications in particular and is, therefore, relevant to debates about healthcare.

Here is a description of the podcast from the Freakonomics website:

When a pharmacist gets a headache, what do you think she’ll buy: Bayer aspirin or the much cheaper store brand? You’ll find out on this week’s episode. Hint: the episode is called “How to Save $1 Billion Without Even Trying.” (You can subscribe to the podcast at iTunes, get the RSS feed, or listen via the media player above. You can also read the transcript; it includes credits for the music you’ll hear in the episode.)

It features Stephen Dubner interviewingMatthew Gentzkow and Jesse Shapiro, a pair of economics professors at the University of Chicago’s Booth School of Business and co-authors (along with Bart J. Bronnenberg and Jean-Pierre Dubé) of a working paper called “Do Pharmacists Buy Bayer? Sophisticated Shoppers and the Brand Premium.” Along the way, we find out if conducting this kind of research leads a researcher to buy more store-brand items himself:

SHAPIRO: I think I probably buy a little more [store brand stuff] now than before we wrote the study. Not so much because of anything I learned from the study, but more because I think I would just feel hypocritical buying the branded good after writing this paper.

You’ll also hear from Steve Levitt about his shopping habits. He says there is one particular item that he’s always willing to splurge on. Can you guess what that is?

Philosophy of Healthcare

Philosophy of Healthcare

The most recent episode of the Philosophy Bites podcast featured an interview with Harvard philosopher Norman Daniels on the philosophy of healthcare.  

Here is a description of the episode: 

Good health opens opportunities to us; poor health closes them down. This suggests that access to adequate healthcare should be part of a theory of justice. Suprisingly this is not a topic that John Rawls addressed in any detail in his A Theory of Justice. Harvard philosopher Norman Daniels discusses justice, inequality,  and healthcare in this episode of the Philosophy Bites podcast. The interviewer is David Edmonds.

“Public health vs individual freedom”

“Public health vs individual freedom”

This was the title of the most recent episode of the BBC’s Moral Maze podcast.  The programme fosters an interesting (although admittedly, at times, dry) debate about the role of the state in regulating public health and its limits.  For instance, do you have an individual right to Twinkies? Does the should the state regulate the size of sodas (NYC)?

Here is a description of the show:  

When should society step in and save us from ourselves? Our apparently insatiable appetites for smoking, drinking and eating are all in the news this week, but where and how should we draw the line between individual freedom and public health? Is it purely a utilitarian calculation; that the consequences are such a drain on the national purse that we can no longer afford the luxury of letting people do what they want? Or does that just reduce the value of our bodies to the lowest common denominator – the bottom line on a balance sheet? And even if we could afford it, should the common good outweigh individual freedom? Is expecting other people to pay for the consequences of our own behaviour immoral? And what if we could invent a cheap and effective pill to allow us to drink as much as we want without suffering a hangover, or eat what we like without the risk of diabetes? We might herald the scientific advance, but would it make us better humans? Is there something morally, as well as corporally corrupting about defiling our bodies with intoxicants and excess? Or does that sound hopelessly Victorian and censorious in an age that has come to prize self-indulgence and hedonism almost as much human rights? Are policies to control our appetites the worst kind of nanny-statism that punishes the responsible and infantilises the rest or a sensible response to a public health crisis?

Combative, provocative and engaging debate chaired by Michael Buerk with Claire Fox, Michael Portillo, Anne McElvoy, Matthew Taylor.

“Public health vs individual freedom”

“Public health vs individual freedom”

This was the title of the most recent episode of the BBC’s Moral Maze podcast.  The programme fosters an interesting (although admittedly, at times, dry) debate about the role of the state in regulating public health and its limits.  For instance, do you have an individual right to Twinkies? Does the should the state regulate the size of sodas (NYC)?

Here is a description of the show:  

When should society step in and save us from ourselves? Our apparently insatiable appetites for smoking, drinking and eating are all in the news this week, but where and how should we draw the line between individual freedom and public health? Is it purely a utilitarian calculation; that the consequences are such a drain on the national purse that we can no longer afford the luxury of letting people do what they want? Or does that just reduce the value of our bodies to the lowest common denominator – the bottom line on a balance sheet? And even if we could afford it, should the common good outweigh individual freedom? Is expecting other people to pay for the consequences of our own behaviour immoral? And what if we could invent a cheap and effective pill to allow us to drink as much as we want without suffering a hangover, or eat what we like without the risk of diabetes? We might herald the scientific advance, but would it make us better humans? Is there something morally, as well as corporally corrupting about defiling our bodies with intoxicants and excess? Or does that sound hopelessly Victorian and censorious in an age that has come to prize self-indulgence and hedonism almost as much human rights? Are policies to control our appetites the worst kind of nanny-statism that punishes the responsible and infantilises the rest or a sensible response to a public health crisis?

Combative, provocative and engaging debate chaired by Michael Buerk with Claire Fox, Michael Portillo, Anne McElvoy, Matthew Taylor.